Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction
about
sameAs
Protein 4.1B contributes to the organization of peripheral myelinated axonsNew insights into neuron-glia communicationCaspr regulates the processing of contactin and inhibits its binding to neurofascinIdentification of a novel oligodendrocyte cell adhesion protein using gene expression profilingAssociation of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibersDisrupted axo-glial junctions result in accumulation of abnormal mitochondria at nodes of ranvierCandidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine developmentWilling to Be Involved in CancerRegulating Axonal Responses to Injury: The Intersection between Signaling Pathways Involved in Axon Myelination and The Inhibition of Axon RegenerationMechanisms of sodium channel clustering and its influence on axonal impulse conductionNeuro-glial interactions at the nodes of Ranvier: implication in health and diseasesHDAC1/2-Dependent P0 Expression Maintains Paranodal and Nodal Integrity Independently of Myelin Stability through Interactions with NeurofascinsProtein 4.1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibresGlutamate excitotoxicity inflicts paranodal myelin splitting and retractionIn vivo deletion of immunoglobulin domains 5 and 6 in neurofascin (Nfasc) reveals domain-specific requirements in myelinated axonsDisruption of axo-glial junctions causes cytoskeletal disorganization and degeneration of Purkinje neuron axonsCaspr and caspr2 are required for both radial and longitudinal organization of myelinated axons.Contactins: emerging key roles in the development and function of the nervous system.Electron tomography of paranodal septate-like junctions and the associated axonal and glial cytoskeletons in the central nervous system.Identification of novel cell-adhesion molecules in peripheral nerves using a signal-sequence trapNovel forms of neurofascin 155 in the central nervous system: alterations in paranodal disruption models and multiple sclerosisNo effect of genetic deletion of contactin-associated protein (CASPR) on axonal orientation and synaptic plasticity.Myelination and regional domain differentiation of the axon.Organization of myelinated axons by Caspr and Caspr2 requires the cytoskeletal adapter protein 4.1BSpatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains.Organization and maintenance of molecular domains in myelinated axonsMyelin recovery in multiple sclerosis: the challenge of remyelinationPeriaxin mutations cause a broad spectrum of demyelinating neuropathies.Loss of glial neurofascin155 delays developmental synapse elimination at the neuromuscular junctionAcceleration of conduction velocity linked to clustering of nodal components precedes myelination.Neurofascin 140 is an embryonic neuronal neurofascin isoform that promotes the assembly of the node of RanvierParanodal myelin retraction in relapsing experimental autoimmune encephalomyelitis visualized by coherent anti-Stokes Raman scattering microscopyPGY repeats and N-glycans govern the trafficking of paranodin and its selective association with contactin and neurofascin-155Fibronectin type III-like domains of neurofascin-186 protein mediate gliomedin binding and its clustering at the developing nodes of Ranvier.Paranodal reorganization results in the depletion of transverse bands in the aged central nervous system.Caspr4 interaction with LNX2 modulates the proliferation and neuronal differentiation of mouse neural progenitor cells.Functions of optic nerve glia: axoglial signalling in physiology and pathology.Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.Neurofascin as a novel target for autoantibody-mediated axonal injury
P2860
Q24339344-61B3AC95-72DC-4ABB-88D6-D87565F30F1CQ24534045-C1424B2D-5613-4732-9B4A-BD42EF134B1AQ24672003-7BA1AB5C-64C4-483E-BE1D-2B5A19CF44D2Q24673067-EE128E07-B811-4F96-997F-B88E831BAF00Q24675297-7E9E600E-2177-4FF6-A877-2320922FF0D6Q24681410-DE2EA974-F219-4553-BE13-583B1D37F0A8Q26269870-61E699D9-E7EB-4A0F-8110-E18B12D9990FQ26738707-BDFC8DB8-5DCB-47FB-A840-1A70C4F16FB2Q26745419-298C9212-CAA7-44A4-89D6-573E71535B31Q26777940-E3B815AC-86D0-4390-902D-C656AA91403EQ26825224-443B5BAD-99D1-457B-BD72-9A452C54B565Q27346711-F8A45759-DB3D-4BD4-9C65-AF91CF386A2FQ28204655-A3D78C74-BB1F-49F8-B931-E6BDFB234FC0Q28475977-2A7AD907-7240-4B65-9A27-DA791312889AQ28512520-CB42E4A3-AA1C-4242-B6D8-8791BFA18FDCQ28591753-66EBA75F-E48C-42FA-B938-164DC4DE1136Q30176395-B2AF11ED-0831-4737-9742-07D92BB52FFCQ30484262-789CE4EA-84C9-4328-BB2B-818F8CF18DCEQ30502019-609ABEFB-C022-44DD-8FEC-36A60A9D094FQ33244434-2D238EE5-0C40-4833-BE84-74953DDF3142Q33656323-E043BB5F-F360-4311-AEA2-B3FA9E8877FDQ33666268-62F3BF91-AD0A-40E5-8F51-F4ED5C7F37F3Q33666278-2090B121-35B6-4B1E-9BC7-1ADC79C0588AQ33720640-C49E6483-5AF4-4587-AD7F-0C823388EAB1Q33722493-F4298919-EE66-483B-A60B-C7D6382C173DQ33726825-CD6E356D-75B1-4F24-9B63-7CDE9E8B70B6Q33772195-2D731CEE-A0BD-47A4-9DAA-E66B0B2A54D4Q34138179-50CC1E08-334A-42E1-A552-C40D1316169BQ34197740-FA77DAE6-ACE5-41BA-8328-31CCF19A911FQ35031427-0C28B662-F7D8-4276-998D-187CB62893B4Q35044841-DBC684D0-B1A7-48FB-9DBA-E1CE129B0B0CQ35510088-13F694C3-8A62-4175-9FE5-A6AEAB909957Q35545326-5AE6AC32-25AB-499C-841F-B1E3CB897896Q35605084-79533207-5B9E-4CE1-BDB2-F1A620BB0285Q35765701-FDB886C3-0EE3-4FCF-85AE-14CCA2AFF97CQ35850065-05493CC8-C582-432F-AB4F-B663AC78B41CQ35944026-D6B363AC-AA55-4C72-B9BA-D2DC8D40EDEFQ35986699-1357DE58-6CCC-4ED9-8AEF-1D428F3ED334Q36005389-44525C4A-C38D-44F9-A11F-355341239950Q36228999-18BDE267-9126-4F8A-9B8E-92FD3A3E9CF7
P2860
Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Neurofascin is a glial recepto ...... mplex at the axoglial junction
@ast
Neurofascin is a glial recepto ...... mplex at the axoglial junction
@en
Neurofascin is a glial recepto ...... mplex at the axoglial junction
@nl
type
label
Neurofascin is a glial recepto ...... mplex at the axoglial junction
@ast
Neurofascin is a glial recepto ...... mplex at the axoglial junction
@en
Neurofascin is a glial recepto ...... mplex at the axoglial junction
@nl
prefLabel
Neurofascin is a glial recepto ...... mplex at the axoglial junction
@ast
Neurofascin is a glial recepto ...... mplex at the axoglial junction
@en
Neurofascin is a glial recepto ...... mplex at the axoglial junction
@nl
P2093
P50
P3181
P1433
P1476
Neurofascin is a glial recepto ...... mplex at the axoglial junction
@en
P2093
Anne-Marie Guennoc
Catherine Lubetzki
Gilles Barbin
Natalia Denisenko-Nehrbass
Perrine Charles
Peter J Brophy
Steven Tait
P304
P3181
P356
10.1016/S0960-9822(01)00680-7
P407
P577
2002-02-01T00:00:00Z